Extracellular sulfatase-2 is overexpressed in rheumatoid arthritis and mediates the TNF-α-induced inflammatory activation of synovial fibroblasts

[1]  J. Hanas,et al.  OKN-007 Alters Protein Expression Profiles in High-Grade Gliomas: Mass Spectral Analysis of Blood Sera , 2022, Brain sciences.

[2]  H. Kim,et al.  Sulfatase 1 and sulfatase 2 as novel regulators of macrophage antigen presentation and phagocytosis , 2021, Yeungnam University journal of medicine.

[3]  M. Mercogliano,et al.  Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy , 2021, Cancers.

[4]  J. Zaia,et al.  Expression of the Extracellular Sulfatase SULF2 Affects Survival of Head and Neck Squamous Cell Carcinoma Patients , 2021, Frontiers in Oncology.

[5]  Anil Kumar Singh,et al.  Regulation of Synovial Inflammation and Tissue Destruction by Guanylate Binding Protein 5 in Synovial Fibroblasts From Patients With Rheumatoid Arthritis and Rats With Adjuvant‐Induced Arthritis , 2020, Arthritis & rheumatology.

[6]  E. Gout,et al.  HS and Inflammation: A Potential Playground for the Sulfs? , 2020, Frontiers in Immunology.

[7]  N. Shaik,et al.  Dissecting the Role of NF-κb Protein Family and Its Regulators in Rheumatoid Arthritis Using Weighted Gene Co-Expression Network , 2019, Front. Genet..

[8]  E. Schwarz,et al.  Selective Sexual Dimorphisms in Musculoskeletal and Cardiopulmonary Pathologic Manifestations and Mortality Incidence in the Tumor Necrosis Factor–Transgenic Mouse Model of Rheumatoid Arthritis , 2019, Arthritis & rheumatology.

[9]  Alireza Hadj Khodabakhshi,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[10]  H. Lortat-Jacob,et al.  The “in and out” of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate , 2016, Glycoconjugate Journal.

[11]  D. Fox,et al.  Synovial cellular and molecular markers in rheumatoid arthritis , 2017, Seminars in Immunopathology.

[12]  F. Allain,et al.  Tumour-necrosis factor-α induces heparan sulfate 6-O-endosulfatase 1 (Sulf-1) expression in fibroblasts. , 2016, The international journal of biochemistry & cell biology.

[13]  B. Kallakury,et al.  Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck , 2016, Oncotarget.

[14]  David S. Wishart,et al.  Heatmapper: web-enabled heat mapping for all , 2016, Nucleic Acids Res..

[15]  J. Phillips,et al.  SULF2, a heparan sulfate endosulfatase, is present in the blood of healthy individuals and increases in cirrhosis. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[16]  D. Pennington,et al.  Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. , 2014, Biochimica et biophysica acta.

[17]  C. Libert,et al.  Regulation and dysregulation of tumor necrosis factor receptor-1. , 2014, Cytokine & growth factor reviews.

[18]  Abd A. Alhasan,et al.  Role of 6-O-Sulfated Heparan Sulfate in Chronic Renal Fibrosis* , 2014, The Journal of Biological Chemistry.

[19]  C. Moser,et al.  The human sulfatase 2 inhibitor 2,4‐disulfonylphenyl‐tert‐butylnitrone (OKN‐007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling , 2013, Genes, chromosomes & cancer.

[20]  Davis J. McCarthy,et al.  Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.

[21]  S. Rosen,et al.  Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate , 2010, Expert opinion on therapeutic targets.

[22]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[23]  G. Firestein,et al.  Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis , 2010, Immunological reviews.

[24]  M. Mayhew.  Tumor Necrosis Factor Inhibitors , 2009 .

[25]  D. D’Lima,et al.  Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage , 2008, Arthritis research & therapy.

[26]  S. Mundlos,et al.  Redundant function of the heparan sulfate 6‐O‐endosulfatases Sulf1 and Sulf2 during skeletal development , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[27]  J. Bradley,et al.  TNF‐mediated inflammatory disease , 2008, The Journal of pathology.

[28]  C. Van Waes,et al.  Role of activated nuclear factor‐κB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck , 2007 .

[29]  A. Koch,et al.  Regulation of interleukin-1β–induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts , 2006 .

[30]  Z. Werb,et al.  HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1 , 2006, BMC Biochemistry.

[31]  M. Kaler,et al.  Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Schwarz,et al.  The TNF-α transgenic mouse model of inflammatory arthritis , 2003, Springer Seminars in Immunopathology.

[33]  Andrew G. D. Bean,et al.  TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection1 , 2002, The Journal of Immunology.

[34]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[35]  G. Adolf,et al.  Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia , 1995, Infection and immunity.

[36]  M. Slevin,et al.  Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. , 1990, Cytokine.

[37]  W. Greene,et al.  Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Zaffaroni,et al.  Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance. , 2017, Current medicinal chemistry.

[39]  C. Farquharson,et al.  Expression of Sulf1 and Sulf2 in cartilage, bone and endochondral fracture healing , 2015, Histochemistry and Cell Biology.

[40]  T. Jenssen,et al.  Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells , 2011, Glycoconjugate Journal.

[41]  A. Koch,et al.  Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. , 2006, Arthritis and rheumatism.

[42]  E. Schwarz,et al.  The TNF-alpha transgenic mouse model of inflammatory arthritis. , 2003, Springer seminars in immunopathology.

[43]  M. Feldmann,et al.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.

[44]  L. Crofford,et al.  Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. , 1996, Arthritis and rheumatism.